Objective: The aim of this study was to assess long-term survival after stroke and to compare survival profiles of patients according to stroke subtypes, age, and sex, using relative survival (RS) method. Methods: All patients with a first-ever stroke were prospectively recorded in the population-based Dijon Stroke Registry from 1987 to 2016. RS is the survival that would be observed if stroke was the only cause of death. Ten-year RS was estimated using a flexible parametric model of the cumulative excess mortality rate, which was obtained by matching the observed all-cause mortality in the stroke cohort to the expected mortality in the general population. A separate model was fitted for each stroke subtypes, first fitted for each age and sex separately, and then adjusted for age and sex. Results: In total, 5,259 patients (mean age 74.9 ± 14.3 years, 53% women) were recorded including 4,469 ischemic strokes (IS), 655 intracerebral hemorrhages (ICH), and 135 undetermined strokes. In IS patients, unadjusted RS was 82% at 1 year and decreased to 62% at 10 years. Adjusted RS showed a lower survival in older age groups (p < 0.001), but no difference between men and women (p = 0.119). In ICH patients, unadjusted RS was 56 and 42% at 1 and 10 years, respectively, with a lower adjusted survival in older age groups (p < 0.001), but no sex differences (p = 0.184). Conclusion: This study showed that RS after stroke is lower in older than in younger patients but without significant sex differences, and survival profiles differ according to stroke subtypes. Since RS allows a better estimation of stroke-related death than observed survival does, especially in old patients, such a method is adapted to provide reliable information when considering long-term outcome.

Keywords:
Stroke, Outcome, Survival analysis, Mortality, Relative survival, Ischemic stroke, Intracerebral hemorrhage, Population-based studies, Stroke registry
1.
Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al.; GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurol
. 2019 May;18(5):439–58.
2.
Feigin VL, Mensah GA, Norrving B, Murray CJ, Roth GA; GBD 2013 Stroke Panel Experts Group. Atlas of the Global Burden of Stroke (1990–2013): the GBD 2013 Study.
Neuroepidemiology
. 2015;45(3):230–6.
3.
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.
Lancet Neurol
. 2009 Apr;8(4):355–69.
4.
Cabral NL, Nagel V, Conforto AB, Amaral CH, Venancio VG, Safanelli J, et al. Five-year survival, disability, and recurrence after first-ever stroke in a middle-income country: A population-based study in Joinvile, Brazil.
Int J Stroke
. 2018 Oct;13(7):725–33.
5.
Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, et al. Two-Year Survival After First-Ever Stroke in a General Population of 1.4 Million Japanese – Shiga Stroke Registry.
Circ J
. 2018 Sep;82(10):2549–56.
6.
Brønnum-Hansen H, Davidsen M, Thorvaldsen P; Danish MONICA Study Group. Long-term survival and causes of death after stroke.
Stroke
. 2001 Sep;32(9):2131–6.
7.
Vibo R, Schneider S, Kõrv J. Long-term survival of young stroke patients: a population-based study of two stroke registries from tartu, estonia.
Stroke Res Treat
. 2012;2012:731570.
8.
Crichton SL, Bray BD, McKevitt C, Rudd AG, Wolfe CD. Patient outcomes up to 15 years after stroke: survival, disability, quality of life, cognition and mental health.
J Neurol Neurosurg Psychiatry
. 2016 Oct;87(10):1091–8.
9.
Luengo-Fernandez R, Paul NL, Gray AM, Pendlebury ST, Bull LM, Welch SJ, et al.; Oxford Vascular Study. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study.
Stroke
. 2013 Oct;44(10):2854–61.
10.
Feigin VL, Barker-Collo S, Parag V, Senior H, Lawes CM, Ratnasabapathy Y, et al.; ASTRO study group. Auckland Stroke Outcomes Study. Part 1: Gender, stroke types, ethnicity, and functional outcomes 5 years poststroke.
Neurology
. 2010 Nov;75(18):1597–607.
11.
Béjot Y, Bailly H, Graber M, Garnier L, Laville A, Dubourget L, et al. Impact of the Ageing Population on the Burden of Stroke: The Dijon Stroke Registry.
Neuroepidemiology
. 2019;52(1-2):78–85.
12.
Béjot Y, Grelat M, Delpont B, Durier J, Rouaud O, Osseby GV, et al. Temporal trends in early case-fatality rates in patients with intracerebral hemorrhage.
Neurology
. 2017 Mar;88(10):985–90.
13.
Feigin V, Norrving B, Sudlow CL, Sacco RL. Updated criteria for population-based stroke and Transient Ischemic Attack incidence studies for the 21st century.
Stroke
. 2018 Sep;49(9):2248–55.
14.
Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, et al. Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology.
Neurology
. 2015 Sep;85(9):821–8.
15.
WHO.
The world health report 2000: Health Systems improving performance
. Geneva: WHO; 2000.
16.
Cronin KA, Feuer EJ. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
Stat Med
. 2000 Jul;19(13):1729–40.
17.
Lambert PC, Dickman PW, Rutherford MJ. Comparison of different approaches to estimating age standardized net survival.
BMC Med Res Methodol
. 2015 Aug;15(1):64.
18.
Estève J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion.
Stat Med
. 1990 May;9(5):529–38.
19.
Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative survival, with application in coronary heart disease.
Stat Med
. 2007 Dec;26(30):5486–98.
20.
Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
Stat Med
. 2002 Aug;21(15):2175–97.
21.
Lambert PC, Royston P. Further development of flexible parametric models for survival analysis.
Stata J
. 2009;9(2):265–90.
22.
Boulanger M, Béjot Y, Rothwell PM, Touzé E. Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta-Analysis.
J Am Heart Assoc
. 2018 Jan;7(2):e007267.
23.
Putaala J. Ischemic stroke in the young: current perspectives on incidence, risk factors, and cardiovascular prognosis.
Eur Stroke J
. 2016 Mar;1(1):28–40.
24.
Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL, et al.; Get With the Guidelines-Stroke Steering Committee and Investigators. Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke.
Circulation
. 2010 Feb;121(7):879–91.
25.
Putaala J, Haapaniemi E, Metso AJ, Metso TM, Artto V, Kaste M, et al. Recurrent ischemic events in young adults after first-ever ischemic stroke.
Ann Neurol
. 2010 Nov;68(5):661–71.
26.
Varona JF. Long-term prognosis of ischemic stroke in young adults.
Stroke Res Treat
. 2010 Dec;2011:879817.
27.
Andersen KK, Olsen TS, Dehlendorff C, Kammersgaard LP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors.
Stroke
. 2009 Jun;40(6):2068–72.
28.
Poon MT, Fonville AF, Al-Shahi Salman R. Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis.
J Neurol Neurosurg Psychiatry
. 2014 Jun;85(6):660–7.
29.
Appelros P, Stegmayr B, Terént A. Sex differences in stroke epidemiology: a systematic review.
Stroke
. 2009 Apr;40(4):1082–90.
30.
Phan HT, Blizzard CL, Reeves MJ, Thrift AG, Cadilhac D, Sturm J, et al. Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): A Meta-Analysis of Individual Participant Data.
Circ Cardiovasc Qual Outcomes
. 2017 Feb;10(2):e003436.
31.
Fall K, Strömberg F, Rosell J, Andrèn O, Varenhorst E; South-East Region Prostate Cancer Group. Reliability of death certificates in prostate cancer patients.
Scand J Urol Nephrol
. 2008;42(4):352–7.
32.
Begg CB, Schrag D. Attribution of deaths following cancer treatment.
J Natl Cancer Inst
. 2002 Jul;94(14):1044–5.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.